Celiac Disease Market size was valued at USD 4.56 Billion in 2024 and is forecasted to grow at a CAGR of 7.4% from 2026 to 2033, reaching USD 8.14 Billion by 2033.
The global Celiac Disease market was valued at approximately USD 2.45 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of around 9.3% from 2023 to 2030. This growth is driven by increasing awareness of gluten related disorders, improved diagnostic rates, and a rising prevalence of celiac disease worldwide. North America held the largest market share in 2022, accounting for over 40% of the total market value, due to the region’s robust healthcare infrastructure, higher patient awareness, and widespread availability of gluten free products. Europe followed closely, contributing around 30% of the market, supported by established diagnostic protocols and government support for autoimmune disease management. Meanwhile, the Asia Pacific region is projected to register the fastest CAGR during the forecast period, owing to increasing urbanization, dietary shifts, and growing recognition of celiac symptoms in emerging economies.
Opportunities in the celiac disease market are expanding, especially in diagnostics and gluten free product development. The market is witnessing innovation in non invasive testing methods, including genetic and serological tests, enhancing early diagnosis and disease management. Additionally, pharmaceutical research into therapeutic alternatives to a strict gluten free diet presents a long term opportunity for market expansion. In the Asia Pacific and Latin America regions, the underdiagnosis of celiac disease remains a challenge, but it also offers significant growth potential as awareness and healthcare access improve. Moreover, rising demand for clean label, allergen free, and nutritionally balanced gluten free foods is fueling product diversification and opening new market segments. Regulatory support and policy reforms in several countries to label gluten free products and subsidize celiac friendly diets further contribute to regional market growth.
Get | Download Sample Copy with TOC, Graphs & List of Figures @ http://verifiedmarketreports.com/download-sample/?rid=737668&utm_source=Pulse_G_April&utm_medium=212
Â
Roche
Merck
Johnson & Johnson
BiolineRx
Pfizer
Innovate Biopharmaceuticals
ImmusanT
Novartis
Bristol-Myers Squibb
Immunomedics
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase Of This Report @ https://www.verifiedmarketreports.com/ask-for-discount/?rid=737668&utm_source=Pulse_G_April&utm_medium=212
Growing demand for below applications around the world has had a direct impact on the growth of the Global Celiac Disease Market
Gluten-Free Grains
Gluten-Free Snacks
Gluten-Free Dairy Products
Gluten-Free Soups and Sauces
Gluten-Free Baked Goods
Supermarkets/Hypermarkets
Health Food Stores
Online Retail
Specialty Stores
Direct Sales
Adults
Children
Senior Citizens
Infants and Toddlers
Pregnant Women
Classical Celiac Disease
Non-Classical Celiac Disease
Silent Celiac Disease
Refractory Celiac Disease
Potential Celiac Disease
Organic Products
Non-Organic Products
Frozen/Chilled Products
Ready-to-Eat Products
Packaged Products
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ https://www.verifiedmarketreports.com/product/celiac-disease-market/
1. Introduction of the Global Celiac Disease Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Celiac Disease Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Celiac Disease Market, By Type
6. Global Celiac Disease Market, By Application
7. Global Celiac Disease Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. Global Celiac Disease Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/